EH

Elanco Animal Health

ELAN
NYSEHealth Care

Recent Patents

elan
over 1 year ago

Filed a patent for "utilization of non-digestible fiber in animals" on Wed, December 28, 2022

New US Patent
elan
over 1 year ago

Filed a patent for "stable formulations of buprenorphine" on Fri, March 22, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "anti-il4 receptor antibodies for veterinary use" on Thu, February 29, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "substituted condensed azines as anthelmintic compounds" on Thu, June 8, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "long-acting anti-il31 antibodies for veterinary use" on Thu, October 5, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "il4/il13 receptor molecules for veterinary use" on Thu, August 15, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "novel heteroaryl-triazole compounds as pesticides" on Thu, November 2, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "guanylate cyclase (gc) stimulator formulations and uses thereof" on Mon, November 7, 2022

New US Patent
elan
over 1 year ago

Filed a patent for "immunostimulatory oligonucleotides" on Thu, October 19, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "quinoline derivatives" on Thu, May 11, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "novel heteroaryl-substituted pyrazine derivatives as pesticides" on Thu, August 3, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "process for making an isoxazoline compound and intermediate thereof" on Thu, August 17, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "chimeric canine anti-cd20 antibody" on Thu, August 17, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "jak inhibitors having a specific particle size distribution" on Thu, December 21, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "tube with application tip" on Thu, August 17, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "anti-il31 antibodies for veterinary use" on Thu, March 28, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "immunogenic probiotic compositions and methods of use including in vaccination" on Thu, February 22, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "n-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections" on Thu, February 22, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "anti-il31 antibodies for veterinary use" on Thu, November 16, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "erythropoietin and analogs for veterinary use" on Thu, December 28, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "bicyclic derivatives" on Wed, May 31, 2023

New US Patent
elan
over 1 year ago

Filed a patent for "tnf alpha and ngf antibodies for veterinary use" on Thu, March 28, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "immunostimulatory oligonucleotides" on Thu, March 7, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "alkylamide substituted, annulated imidazoles and use thereof as insecticides" on Thu, August 1, 2024

New US Patent
elan
over 1 year ago

Filed a patent for "methods and formulations for reducing bovine emissions" on Thu, March 21, 2024

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...